Cooper Companies: Solid Earnings and Fertility Recovery Offset by Sluggish Core Vision Growth, Warranting a Hold Rating

Analyst Patrick Wood of Morgan Stanley maintained a Hold rating on Cooper Co, retaining the price target of $83.00.

Patrick Wood has given his Hold rating due to a combination of factors that balance near‑term positives with lingering structural questions. He acknowledges that Cooper delivered better‑than‑expected earnings supported by operating leverage, firmer pricing in contact lenses, and encouraging recovery trends in its fertility business, particularly in the U.S., all of which indicate underlying business resilience.

At the same time, he underscores that overall contact lens revenue growth remains muted at around low single digits, with another lackluster quarter likely ahead, which falls short of the mid‑single‑digit pace expected for the broader market. Until Cooper’s core vision segment accelerates to align with industry growth and the ongoing strategic review provides greater clarity, he sees the shares as likely to trade sideways, justifying a neutral, Hold stance rather than a more decisive rating change.

In another report released today, Citi also maintained a Hold rating on the stock with a $87.00 price target.